Dr. Nina Niu Sanford (@NiuSanford)
@NiuSanford
GI Radiation Oncologist | Boston, @Princeton, @harvardmed, now @UTSWNews in Dallas | clinical trials | buying in bulk | Tweets=own | FCOI:
1.9K 正在关注 10.2K 粉丝
How do we define the role of SBRT in HCC amidst many other available local modalities? Do we need a Ph III RCT with OS endpoint?
Thoughts from @ldawsonmd, liver SBRT pioneer now s/p after decades of experience leading HCC trials.
显示更多
Learn about NRG-GI012, a Ph3 RCT of IO +/- SBRT in HCC w Macrovascular Invasion!
W the great Drs. @jen_wo_xrt (PI) & @ldawsonmd.
Please enroll on this pragmatic RCT to help define the role of SBRT in a pt population w significant unmet need.
Clips here, full video link below.
显示更多
